TRIPHASE RESEARCH AND DEVELOPMENT I CORP.;DANA-FARBER CANCER INSTITUTE INC.;NEREUS PHARMACEUTICALS INC.
发明人:
申请号：
IL18350607
公开号：
IL183506A
申请日:
2007.05.29
申请国别(地区):
IL
年份:
2015
代理人:
摘要：
Disclosed herein are compositions and methods for treating neoplastic diseases. Included are compositions and methods that are effective against multiple myeloma cells resistant to conventional and bortezomib treatment. Furthermore, combination treatment with two different proteosome inhibitors is shown to be synergistic for treating multiple myeloma.
